XML 78 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Debt (Details) - USD ($)
1 Months Ended 12 Months Ended
Feb. 28, 2020
Feb. 21, 2020
Feb. 29, 2020
Nov. 30, 2018
Nov. 30, 2016
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]                
Total long-term debt           $ 619,170,000 $ 455,041,000  
Long-term debt interest expense                
Stated coupon interest           42,625,000 28,811,000 $ 9,316,000
Interest shortfall on 2035 notes, net           17,643,000    
Loss on extinguishment of debt           (15,464,000)    
Amortization of deferred finance cost           1,960,000 3,051,000 $ 1,166,000
Issuer II Class C Units                
Long-term debt interest expense                
Percentage of economic interest   85.00%            
Percentage of equity interest   75.00%            
9.5% Non-Recourse 2035 Notes                
Debt Instrument [Line Items]                
Principal amount   $ 400,000,000.0       418,572,000    
Less: 5% retained by the Company           (20,929,000)    
Unamortized debt issuance costs           $ (3,847,000)    
Long-term debt interest expense                
Interest rate (as a percent)   9.50%       9.50%    
Percentage of note to be sold   0.95%            
Percentage of note to be retained   5.00%            
Net principal   $ 17,600,000       $ 397,600,000    
Estimated fair value           399,600,000    
Unamortized debt issuance costs           3,847,000    
9.0% Non-Recourse 2033 Notes                
Debt Instrument [Line Items]                
Principal amount             247,734,000  
Less: 5% retained by the Company             (12,387,000)  
Unamortized debt issuance costs           $ (1,589,000) $ (6,196,000)  
Long-term debt interest expense                
Proceeds from issuance of debt       $ 250,000,000.0        
Interest rate (as a percent)       9.00%   9.00% 9.00%  
Loss on extinguishment of debt           $ 15,500,000    
Unamortized debt issuance costs           1,589,000 $ 6,196,000  
Unamortized deferred financing costs $ 1,800,000              
Creditors fees $ 500,000     $ 4,400,000        
Third party fees       $ 300,000        
3.25% Convertible Senior Notes Due 2023                
Debt Instrument [Line Items]                
Principal amount           230,000,000 230,000,000  
Less: 5% retained by the Company         $ (7,500,000)      
Unamortized debt issuance costs           $ (3,037,000) $ (4,110,000)  
Long-term debt interest expense                
Proceeds from issuance of debt         $ 222,500,000      
Interest rate (as a percent)         3.25% 3.25% 3.25%  
Unamortized debt issuance costs           $ 3,037,000 $ 4,110,000  
Conversion rate, in shares           29.0276    
Principal amount for conversion rate           $ 1,000    
Conversion price (in dollars per share)           $ 34.45    
Redemption price to principal amount, in percent           100.00%    
3.25% Convertible Senior Notes Due 2023 | Level 2                
Long-term debt interest expense                
Notes fair value           $ 217,900,000 $ 236,000,000.0  
TRC                
Long-term debt interest expense                
Percentage of economic interest   85.00%       85.00%    
Percentage of equity interest           85.00%    
TRC | Minimum                
Long-term debt interest expense                
Upward tiering royalties (as a percent)   6.50%            
TRC | Maximum                
Long-term debt interest expense                
Upward tiering royalties (as a percent)   10.00%            
TRC | Issuer II Class C Units                
Long-term debt interest expense                
Percentage of economic interest   63.75%            
TRC | Arbitration against Innoviva and TRC                
Long-term debt interest expense                
Percentage of economic interest           0.85%    
Theravance Biopharma R&D, Inc. | 9.5% Non-Recourse 2035 Notes                
Long-term debt interest expense                
Interest rate (as a percent)           5.00%    
Theravance Biopharma R&D, Inc. | 9.0% Non-Recourse 2033 Notes                
Long-term debt interest expense                
Interest rate (as a percent)       5.00%        
Redemption price to principal amount, in percent     5.00%